| abstract |
The invention relates to adrenoceptor ± 2C receptor antagonists for use in a method for the treatment and / or prophylaxis of concomitant and / or secondary diseases of diabetes mellitus, diabetic heart disease, diabetic coronary heart disease, diabetic coronary microvascular heart disease, diabetic heart failure, diabetic cardiomyopathy and myocardial infarction, diabetic microangiopathy, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic erectile dysfunction, diabetic ulcers on the extremities, diabetic foot ulcers, for promoting diabetic wound healing, and for promoting wound healing of diabetic foot ulcers. |